Works matching DE "ENTACAPONE"
Results: 89
Effect of entacapone on plasma homocysteine levels in Parkinson’s disease patients.
- Published in:
- Neurological Sciences, 2010, v. 31, n. 5, p. 565, doi. 10.1007/s10072-010-0262-0
- By:
- Publication type:
- Article
Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers.
- Published in:
- Acta Neurologica Scandinavica, 2013, v. 127, n. 2, p. 124, doi. 10.1111/j.1600-0404.2012.01700.x
- By:
- Publication type:
- Article
Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations.
- Published in:
- Acta Neurologica Scandinavica, 2005, v. 111, n. 1, p. 21, doi. 10.1111/j.1600-0404.2004.00363.x
- By:
- Publication type:
- Article
Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study).
- Published in:
- Acta Neurologica Scandinavica, 2002, v. 105, n. 4, p. 245, doi. 10.1034/j.1600-0404.2002.1o174.x
- By:
- Publication type:
- Article
Levodopa-carbidopa-entacapone overdose presenting as altered mental status, xanthoderma, and yellowish sclera.
- Published in:
- Signa Vitae, 2018, v. 14, n. 2, p. 75, doi. 10.22514/SV142.102018.12
- By:
- Publication type:
- Article
Effects of levodopa-carbidopa-entacapone and smoked cocaine on facial affect recognition in cocaine smokers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effect of the Catechol-O-Methyltransferase Inhibitors Tolcapone and Entacapone on Fatty Acid Metabolism in HepaRG Cells.
- Published in:
- Toxicological Sciences, 2018, v. 164, n. 2, p. 477, doi. 10.1093/toxsci/kfy101
- By:
- Publication type:
- Article
An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI.
- Published in:
- Toxicological Sciences, 2018, v. 161, n. 2, p. 412, doi. 10.1093/toxsci/kfx219
- By:
- Publication type:
- Article
Capture Compound Mass Spectrometry Sheds Light on the Molecular Mechanisms of Liver Toxicity of Two Parkinson Drugs.
- Published in:
- Toxicological Sciences, 2010, v. 113, n. 1, p. 243, doi. 10.1093/toxsci/kfp236
- By:
- Publication type:
- Article
Parkinson Treatment Approval.
- Published in:
- JAMA: Journal of the American Medical Association, 1999, v. 282, n. 21, p. 1995, doi. 10.1001/jama.282.21.1995-JFD90010-3-1
- By:
- Publication type:
- Article
Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial.
- Published in:
- European Journal of Neurology, 2012, v. 19, n. 6, p. 820, doi. 10.1111/j.1468-1331.2011.03614.x
- By:
- Publication type:
- Article
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
- Published in:
- European Journal of Neurology, 2011, v. 18, n. 12, p. 1373, doi. 10.1111/j.1468-1331.2011.03512.x
- By:
- Publication type:
- Article
Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.
- Published in:
- European Journal of Neurology, 2011, v. 18, p. 3, doi. 10.1111/j.1468-1331.2010.03326.x
- By:
- Publication type:
- Article
Early versus delayed initiation of entacapone in levodopa-treated patients with Parkinson’s disease: a long-term, retrospective analysis.
- Published in:
- European Journal of Neurology, 2009, v. 16, n. 12, p. 1305, doi. 10.1111/j.1468-1331.2009.02726.x
- By:
- Publication type:
- Article
Bimodal administration of entacapone in Parkinson’s disease patients improves motor control.
- Published in:
- European Journal of Neurology, 2008, v. 15, n. 3, p. 268, doi. 10.1111/j.1468-1331.2007.02043.x
- By:
- Publication type:
- Article
Long-term effectiveness and quality of life improvement in entacapone-treated Parkinson's disease patients: the effects of an early therapeutic intervention.
- Published in:
- European Journal of Neurology, 2007, v. 14, n. 3, p. 282, doi. 10.1111/j.1468-1331.2006.01635.x
- By:
- Publication type:
- Article
Delayed administration may improve entacapone effects in parkinsonian patients non-responding to the drug.
- Published in:
- European Journal of Neurology, 2004, v. 11, n. 9, p. 593, doi. 10.1111/j.1468-1331.2004.00860.x
- By:
- Publication type:
- Article
The tolerability and efficacy of entacapone over 3 years in patients with Parkinson's disease.
- Published in:
- European Journal of Neurology, 2003, v. 10, n. 2, p. 137, doi. 10.1046/j.1468-1331.2003.00559.x
- By:
- Publication type:
- Article
Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.
- Published in:
- Journal of Neural Transmission, 2003, v. 110, n. 3, p. 239, doi. 10.1007/s00702-002-0799-z
- By:
- Publication type:
- Article
The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in l-DOPA/carbidopa treated rats.
- Published in:
- Journal of Neural Transmission, 2001, v. 108, n. 2, p. 189, doi. 10.1007/s007020170087
- By:
- Publication type:
- Article
Comparative toxicological study on the hepatic safety of entacapone and tolcapone in the rat.
- Published in:
- Journal of Neural Transmission, 2001, v. 108, n. 1, p. 79, doi. 10.1007/s007020170099
- By:
- Publication type:
- Article
The Liver Toxicity Biomarker Study Phase I: Markers for the Effects of Tolcapone or Entacapone.
- Published in:
- Toxicologic Pathology, 2012, v. 40, n. 6, p. 951, doi. 10.1177/0192623312444026
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications October-December 2014.
- Published in:
- Assay & Drug Development Technologies, 2015, v. 13, n. 6, p. 325, doi. 10.1089/adt.2015.29016.patdrrr
- By:
- Publication type:
- Article
Entacapone detection by a GOQDs-molecularly imprinted silica fluorescent chemical nanosensor.
- Published in:
- Analytical & Bioanalytical Chemistry, 2019, v. 411, n. 5, p. 1075, doi. 10.1007/s00216-018-1534-4
- By:
- Publication type:
- Article
Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinsons disease.
- Published in:
- Current Medical Research & Opinion, 2010, v. 26, n. 7, p. 1543, doi. 10.1185/03007991003780628
- By:
- Publication type:
- Article
Naturalistic evaluation of entacapone in patients with signs and symptoms of L-dopa wearing-off .
- Published in:
- 2008
- By:
- Publication type:
- journal article
The Association between Adherence to Levodopa/Carbidopa/Entacapone Therapy and Healthcare Utilization and Costs among Patients with Parkinson's Disease A Retrospective Claims-Based Analysis.
- Published in:
- CNS Drugs, 2011, v. 25, n. 1, p. 53, doi. 10.2165/11538970-000000000-00000
- By:
- Publication type:
- Article
Efficacy and Safety of Adjuvant Treatment with Entacapone in Advanced Parkinson’s Disease with Motor Fluctuation: A Systematic Meta-Analysis.
- Published in:
- European Neurology, 2017, v. 78, n. 3/4, p. 143, doi. 10.1159/000479555
- By:
- Publication type:
- Article
Is There a Difference between Levodopa/ Dopa-Decarboxylase Inhibitor and Entacapone and Levodopa/Dopa-Decarboxylase Inhibitor Dose Fractionation Strategies in Parkinson’s Disease Patients Experiencing Symptom Re-Emergence due to Wearing-Off?
- Published in:
- European Neurology, 2009, v. 61, n. 2, p. 69, doi. 10.1159/000177938
- By:
- Publication type:
- Article
The Influence of Levodopa and the COMT Inhibitor on Serum Vitamin B12 and Folate Levels in Parkinson’s Disease Patients.
- Published in:
- European Neurology, 2007, v. 58, n. 2, p. 96, doi. 10.1159/000103644
- By:
- Publication type:
- Article
Knee Lichenification In Parkinson's Disease: "Parkinson Knees".
- Published in:
- Medicine & Health Rhode Island, 2009, v. 92, n. 12, p. 415
- By:
- Publication type:
- Article
Thermal behavior of entacapone, a catechol-O-methyltransferase inhibitor used in Parkinson’s disease.
- Published in:
- Journal of Thermal Analysis & Calorimetry, 2018, v. 134, n. 1, p. 711, doi. 10.1007/s10973-018-7097-y
- By:
- Publication type:
- Article
Thermal decomposition kinetics of the antiparkinson drug 'entacapone' under isothermal and non-isothermal conditions.
- Published in:
- Journal of Thermal Analysis & Calorimetry, 2017, v. 130, n. 3, p. 2359, doi. 10.1007/s10973-017-6664-y
- By:
- Publication type:
- Article
Entacapone increases and prolongs the central effects ofl-DOPA in the 6-hydroxydopamine-lesioned rat.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, v. 370, n. 5, p. 388, doi. 10.1007/s00210-004-0984-8
- By:
- Publication type:
- Article
Cathecol-O-methyltransferase inhibitors: another possibly useful pharmacological tool for treating Parkinson's disease in pregnancy?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Validation of UV Spectrophotometric Method for Quantitative Determination of Entacapone in Tablets Using Experimental Design of Plackett-Burman for Robustness Evaluation and Comparison with HPLC.
- Published in:
- Analytical Letters, 2008, v. 41, n. 4, p. 571, doi. 10.1080/00032710801912730
- By:
- Publication type:
- Article
Determination of Entacapone by Differential Pulse Polarography in Pharmaceutical Formulation.
- Published in:
- Analytical Letters, 2008, v. 41, n. 1, p. 56, doi. 10.1080/00032710701746774
- By:
- Publication type:
- Article
Potential of microemulsified entacapone drug delivery systems in the management of acute Parkinson's disease.
- Published in:
- Journal of Acute Disease, 2016, v. 5, n. 4, p. 315, doi. 10.1016/j.joad.2016.05.004
- By:
- Publication type:
- Article
Entacapone improves the availability of l-dopa in plasma by decreasing its peripheral metabolism independent of l-dopa/carbidopa dose.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 54, n. 4, p. 363, doi. 10.1046/j.1365-2125.2002.01654.x
- By:
- Publication type:
- Article
Effect of the catechol-O -methyltransferase inhibitor entacapone on the steady-state pharmacokinetics and pharmacodynamics of warfarin.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 5, p. 485, doi. 10.1046/j.1365-2125.2002.01587.x
- By:
- Publication type:
- Article
Cost effectiveness of treatment of Parkinson's disease with entacapone in the United States.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Pooled analysis of phase III with entacapone in Parkinson's disease.
- Published in:
- Acta Neurologica Scandinavica, 2014, v. 130, n. 4, p. 239, doi. 10.1111/ane.12278
- By:
- Publication type:
- Article
Twelve-month safety of entacapone in patients with Parkinson’s disease.
- Published in:
- European Journal of Neurology, 2001, v. 8, n. 1, p. 53, doi. 10.1046/j.1468-1331.2001.00168.x
- By:
- Publication type:
- Article
Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi- Drug and Extensively Drug Resistant Tuberculosis.
- Published in:
- PLoS Computational Biology, 2009, v. 5, n. 7, p. 1, doi. 10.1371/journal.pcbi.1000423
- By:
- Publication type:
- Article
Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson's disease.
- Published in:
- Journal of Neurology, 2007, v. 254, p. IV37, doi. 10.1007/s00415-007-4007-9
- By:
- Publication type:
- Article
Extrapyramidal disorders.
- Published in:
- 2006
- Publication type:
- Abstract
Opicapone: Once-Daily COMT Inhibitor for the Treatment of Wearing Off in Parkinson's Disease.
- Published in:
- Senior Care Pharmacist, 2022, v. 37, n. 2, p. 55, doi. 10.4140/TCP.n.2022.55
- By:
- Publication type:
- Article
Study of Relative Association, Apparent Molar Compressibility and Free Length of Entacapone API in alcohols at different Frequencies.
- Published in:
- Indian Journal of Pharmaceutical Education & Research, 2016, v. 50, n. 4, p. 703, doi. 10.5530/ijper.50.4.23
- By:
- Publication type:
- Article
Dissolution Rate Enhancement of Entacapone and Formulation of its Oro-Dispersible Tablets: Applying Statistical Design.
- Published in:
- Indian Journal of Pharmaceutical Education & Research, 2016, v. 50, n. 4, p. 549, doi. 10.5530/ijper.50.4.7
- By:
- Publication type:
- Article
A Novel Approach using Hydrotropic Solubalization Technique for Quantitative Estimation of Entacapone in Bulk Drug and Dosage Form.
- Published in:
- Advanced Pharmaceutical Bulletin, 2013, v. 3, n. 2, p. 409, doi. 10.5681/apb.2013.065
- By:
- Publication type:
- Article